News Detail
Sweden, 7 Feb 2023: The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate to severe psoriasis; but in this p......
View Details
Source : News Medical Net
Arthritis
Basal Cell Carcinoma
Cancer
Carcinoma
Cell
Dermatology
Drugs
Epidemiology
Health Care
Hospital
Kidney
Kidney Disease
Light Therapy
Liver
Malignant
Medicine
Melanoma
Methotrexate
Psoriasis
Research
Rheumatoid Arthritis
Rheumatology
Skin
Skin Cancer
Squamous Cell Carcinoma
Related News
- Study links personal care products to increased hormonal disruptions in children (15-09-2024)
- Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)
- Protein-lipid particles to deliver genetic medicine (11-09-2024)
- Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)
- Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)
- Human gut microbiome: A source of new antibiotic peptides (26-08-2024)
- IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)
- Scientists control bacterial mutations to preserve antibiotic effectiveness (27-07-2024)
- Dual action antibiotic could make bacterial resistance nearly impossible (25-07-2024)
- Metoprolol, Tamsulosin and Bromocriptine combination treatment shows promise in the treatment of retinal degenerations (23-07-2024)